Scanning Electron Microscopy (SEM) Evaluation of the Ultrastructural Effects on Conjunctival Epithelial Cells of a New Multiple-Action Artificial Tear Containing Cross-Linked Hyaluronic Acid, Cationic Liposomes and Trehalose
-
Published:2024-08-23
Issue:9
Volume:12
Page:1945
-
ISSN:2227-9059
-
Container-title:Biomedicines
-
language:en
-
Short-container-title:Biomedicines
Author:
Troisi Mario1ORCID, Del Prete Salvatore2, Troisi Salvatore3ORCID, Marasco Daniela2ORCID, Rinaldi Michele1ORCID, Costagliola Ciro1ORCID
Affiliation:
1. Eye Clinic, Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, 80131 Naples, Italy 2. Service Biotech s.r.l., 80121 Naples, Italy 3. Ophthalmologic Unit, Salerno Hospital University, 84100 Salerno, Italy
Abstract
The authors performed an ex vivo and in vivo evaluation of the ultrastructural effects on the conjunctival epithelial cells of a new multiple-action tear substitute containing cross-linked hyaluronic acid, lipids and trehalose (Trimix®), using scanning electron microscopy (SEM) with conjunctival impression cytology. The ex vivo study highlights the persistence and distribution of the product at 5 and 60 min on a monolayer of conjunctival epithelial cells and an increase in microvilli density at the 60 min evaluation. In vivo examination was conducted on three subjects with different grades of ocular surface inflammation, treated with one drop of the product twice daily for thirty days. At the baseline (T0) and twelve hours after the last administration of the tear drop (T30), impression cytology of the upper bulbar conjunctiva for SEM evaluation of conjunctival epithelial cells was carried out. Slit lamp examination (SLE), corneal and conjunctival Fluotest, tear film break-up time (TBUT), and ocular surface disease index (OSDI) questionnaires were also performed to correlate the ultrastructural results with the clinical findings. After 30 days of treatment, a significant improvement in all clinical and symptomatic parameters and in the condition of the ocular surface was detected, with microvillar regeneration and strengthening in all the patients, and a complete restoration in 2/3 of them. The persistence and distribution of the product on the epithelial cells was also noted 12 h after the last administration. The results, therefore, suggest a marked epitheliotropic effect along with a high residence time of the tear substitute.
Reference45 articles.
1. Labetoulle, M., Benitez-del-Castillo, J.M., Barabino, S., Herrero Vanrell, R., Daull, P., Garrigue, J.-S., and Rolando, M. (2022). Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease. Int. J. Mol. Sci., 23. 2. Dry eye disease treatment: The role of tear substitutes, their future, and an updated classification;Barabino;Eur. Rev. Med. Pharmacol. Sci.,2020 3. Effects of a New Formulation of Multiple-Action Tear Substitute on Objective Ocular Surface Parameters and Ocular Discomfort Symptoms in Patients with Dry Eye Disease;Vigo;Ophthalmol. Ther.,2022 4. The corneal epithelial surface in the eyes of vertebrates: Environmental and evolutionary influences on structure and function;Collin;J. Morphol.,2006 5. Grumetto, L., Del Prete, A., Ortosecco, G., Barbato, F., Del Prete, S., Borrelli, A., Schiattarella, A., Mancini, R., and Mancini, A. (2015). Study on the Protective Effect of a New Manganese Superoxide Dismutase on the Microvilli Eyes Exposed to UV Radiation of Rabbit. BioMed. Res. Int., 2015.
|
|